ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference

About this update from Ani Pharmaceuticals, Inc.

[{"type":"text","content":" BAUDETTE, Minn.--(BUSINESS WIRE)--\nANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Healthcare Conference in New York City as follows:\n\n\n\n\nDate:\n\n\n\n\n\n \n \n \n \n\nFriday, June 9, 2023\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n \n \n \n \n\n \n\n\n\n\n\n\n\n\nTime:\n\n\n\n\n\n \n \n \n \n\n8:30 a.m. ET\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n \n \n \n \n\n \n\n\n\n\n\n\n\n\nWebcast:\n\n\n\n\n\n \n \n \n \n\nClick here\n\n\n\n\n\n\n\nThe live and archived webcast of the presentation will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.\n\n\nTo schedule a 1x1 meeting with the Company, please contact Corporate Access at Jefferies.\n\n\nAbout ANI\n\n\nANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230522005649/en/\n\nInvestor Relations:\nLisa M. Wilson, In-Site Communications, Inc.\nT: 212-452-2793\nE: [email protected]\n\n\nSource: ANI Pharmaceuticals, Inc.","length":5730,"tagName":"div"}]

More updates from Ani Pharmaceuticals, Inc.